Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines

Journal of Veterinary Medical Science

Volumn 71, Issue 6, 2009, Pages 769-777

  Hiraoka, Hiroko ^a   Minami, Koji ^a   Kaneko, Naoki ^a   Shimokawa Miyama, Takako ^a   Okamura, Yasuhiko ^b   Mizuno, Takuya ^a   Okuda, Masaru ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b IWATE UNIVERSITY   (Japan)

Author keywords

Cancer; Canine; DNA methylation; Gene expression; Lymphoma leukemia

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; MESSENGER RNA; TUMOR PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CPG ISLAND; DNA METHYLATION; DOG; DOG DISEASE; GENETICS; LYMPHOMA; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ACID ANHYDRIDE HYDROLASES; ANIMALS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DOG DISEASES; DOGS; LYMPHOMA; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 68849128750     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.71.769     Document Type: Article

References (40)

1. Ahmadian, M., Wistuba, I. I., Fong, K. M., Behrens, C., Kodagoda, D. R., Saboorian, M. H., Shay, J., Tomlinson, G. E., Blum, J., Minna, J. D. and Gazdar, A. F. 1997. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res. 57: 3664-3668.
2. Albitar, M., Manshouri, T., Gidel, C., Croce, C., Kornblau, S., Pierce, S. and Kantarjian, H. M. 2001. Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia. Leuk. Res. 25: 859-864.
3. Arlt, M. F., Durkin, S. G., Ragland, R. L. and Glover, T. W. 2006. Common fragile sites as targets for chromosome rearrangements. DNA Repair 5: 1126-1135.
4. Arun, B., Kilic, G., Yen, C., Foster, B., Yardley, D. A., Gaynor, R. and Ashfaq, R. 2005. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers. Cancer Epidemiol. Biomarkers Prev. 14: 1681-1685.
5. Chen, P. M., Yang, M. H., Hsiao, L. T., Yu, I. T., Chu, C. J., Chao, T. C., Yen, C. C., Wang, W. S., Chiou T. J. and Liu, J. H. 2004. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma. Oncol. Rep. 11: 349-356.
6. Corbin, S., Neilly, M. E., Espinosa R. III, Davis, E. M., McKeithan, T. W. and Le Beau, M. M. 2002. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/ common fragile site at 3p14.2 in tumors. Cancer Res. 62: 3477-3484.
7. Fong, L. Y., Fidanza, V., Zanesi, N., Lock, L. F., Siracusa, L. D., Mancini, R., Siprashvili, Z., Ottey, M., Martin, S. E., Druck, T., McCue, P. A., Croce, C. M. and Huebner, K. 2000. Muir-Torre-like syndrome in Fhit-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 97: 4742-4747.
8. Fong, K. M., Biesterveld, E. J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S. A., Ahmadian, M., Ong, S. T., Rassool, F. V., Zimmerman, P. V., Giaccone, G., Gazdar, A. F. and Minna, J. D. 1997. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial legions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res. 57: 2256-2267.
9. Fosmire, S. P., Thomas, R., Jubala, C. M., Wojcieszyn, J. W., Valli, V. E., Getzy, D. M., Smith, T. L., Gardner, L. A., Ritt, M. G., Bell, J. S., Freeman, K. P., Greenfield, B. E., Lana, S. E., Kisseberth, W. C., Helfand, S. C., Cutter, G. R., Breen, M. and Modiano, J. F. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. 2007. Vet. Pathol. 44: 467-478.
10. Gartenhaus, R. B. 1997. Allelic loss determination in chronic lymphocytic leukemia by immunomagnetic bead sorting and microsatellite marker analysis. Oncogene 14: 375-378.
11. Glover, T. W. 2006. Common fragile sites. Cancer Lett. 232: 4-12.
12. Guerin, L. A., Hoffman, H. T., Zimmerman, M. B. and Robinson, R. A. 2006. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma. Arch. Pathol. Lab. Med. 130: 158-164.
13. Hallas, C., Albitar, M., Letofsky, J., Keating, M. J., Huebner, K. and Croce, C. M. 1999. Loss of FHIT expression in acute lymphoblastic leukemia. Clin. Cancer Res. 5: 2409-2414.
14. Han, S. Y., Iliopoulos, D., Druck, T., Guler, G., Grubbs, C. J., Pereira, M., Zhang, Z., You, M., Lubet, R. A., Fong, L. Y. and Huebner, K. 2004. CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors. Oncogene 23: 3990-3998.
15. Hiraoka, H., Minami, K., Kaneko, N., Miyama-Shimokawa, T., Mizuno, T. and Okuda, M. Molecular cloning of the canine fragile histidine triad (FHIT) gene and Fhit protein expression in canine peripheral blood mononuclear cells. J. Vet. Med. Sci. (in press).
16. Huebner, K. and Croce, C. M. 2003. Cancer and the FRA3B/ FHIT fragile locus: it's a HIT. Br. J. Cancer 88: 1501-1506.
17. Iliopoulos, D., Guler, G., Han, S. Y., Druck, T., Ottey, M., McCorkell, K. A. and Huebner, K. 2006. Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett. 232: 27-36.
18. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T., Huebner, K. and Croce, C. M. 1997. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. U.S.A. 94: 14584-14589.
19. Ishii, H., Wang, Y. and Huebner, K. 2007. A Fhit-ing role in the DNA checkpoint response. Cell Cycle 6: 1044-1048.
20. Ishii, H., Mimori, K., Inoue, H., Inageta, T., Ishikawa, K., Semba, S., Druck, T., Trapasso, F., Tani, K., Vecchione, A., Croce, C. M., Mori, M. and Huebner, K. 2006. Fhit modulates the DNA damage checkpoint response. Cancer Res. 66: 11287-11292.
21. Iwai, T., Yokota, S., Nakao, M., Nakazawa, N., Taniwaki, M., Kimura, T., Sonoda, Y., Kaneko, H., Okuda, T., Azuma, H., Oka, T., Takeda, T., Watanabe, A., Kikuta, A., Asami, K., Sekine, I., Matsushita, T., Tsuchiya, T., Mimaya, J., Koizumi, S., Ohata, S., Miyake, M., Takaue, Y., Iwai, A., Nishikawa, K., Matsumoto, K., Kawakami, K., Hyakuna, N. and Fujimoto, T. 1998. Frequent aberration of FHIT gene expression in acute leukemias. Cancer Res. 58: 5182-5187.
22. Larson, A. A., Kern, E., Curtiss, S., Gordon, R., Cavenee, W. K. and Hampton, G. M. 1997. High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res. 57: 4082-4090.
23. Momoi, Y., Okai, Y., Watari, T., Goitsuka, R., Tsujimoto, H. and Hasegawa, A. 1997. Establishment and characterization of a canine T-lymphoblastid cell line derived from malignant lymphoma. Vet. Immnol. Immunophol. 59: 11-20.
24. Nakaichi, M., Taura, Y., Kanki, M, Mamba, K., Momoi, Y., Tsujimoto, H. and Nakama, S. 1996. Establishment and characterization of a new canine B-cell leukemia cell line. J. Vet. Med. Sci. 58: 469-471.
25. Peters, I. R., Peeters, D., Helps, C. R. and Day, M. J. 2007. Development and application of multiple internal reference (housekeeper) gene assays for accurate normalization of canine gene expression studies. Vet. Immunol. Immunopathol. 117: 55-66.
26. Peters, U. R., Hasse U., Opplinger, E., Tschan, M., Ong, S. T., Rassool, F. V., Borisch, B., Tobler, A. and Fey, M. F. 1999. Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukemia. Oncogene 18: 79-85.
27. Shridhar, R., Shridhar, V., Wang, X., Paradee, W., Dugan, M., Sarkar, F., Wilke, C., Glover, T. W., Vaitkevicius, V. K. and Smith, D. I. 1996. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res. 56: 434-4350.
28. Smith, D. I., McAvoy, S., Zhu, Y. and Perez, D. S. 2007. Large common fragile site genes and cancer. Semin. Cancer Biol. 17: 31-41.
29. Sugimoto, K., Yamada, K., Miyagawa, K., Hirai, H., Oshimi, K. 1997. Decreased or altered expression of the FHIT gene in human leukemias. Stem Cells 15: 223-228.
30. Tanaka, H., Shimada, Y., Harada, H., Shinoda, M., Hatooka, S., Imamura, M. and Ishizaki, K. 1998. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res. 58: 3429-3434.
31. Toledo, G., Sola, J. J., Lozano, M. D., Soria, E. and Pardo, J. 2004. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer. Mod. Pathol. 17: 440-448.
32. Vail, D. M. and Young, K. M. 2007. Canine lymphoma and lymphoid leukemia. pp. 699-733. In: Small Animal Clinical Oncology, 4th ed. (Withrow, S. J. and Vail, D. M. eds.), Saunders, Philadelphia.
33. Virmani, A. K., Muller, C., Rathi, A., Zoechbauer-Mueller, S., Mathis, M. and Gazdar, A. F. 2001. Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7: 584-589.
34. Weiske, J., Albring, K. F. and Huber, O. 2007. The tumor suppressor Fhit acts as a repressor of β-catenin transcriptional activity. Proc. Natl. Acad. Sci. U.S.A. 104: 20344-20349.
35. Yamazaki, J., Baba, K., Goto-Koshino, Y., Setoguchi-Mukai, A, Fujino, Y., Ohno, K. and Tsujimoto, H. 2008. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction. Vet. Immunol. Immunopathol. 126: 321-331.
36. Yang, H. W., Piao, H. Y., Taki, T., Chen, T., Hashizume, K., Ohnishi, H., Bessho, F., Yanagisawa, M., Matsuo, Y. and Hayashi, Y. 1999. Pattern of FHIT gene expression in normal and leukaemic cells. Int. J. Cancer 81: 897-901.
37. Yang, Y., Takeuchi, S., Hofmann, W. K., Ikezoe, T., van Dongen, J. J., Szczepański, T., Bartram, C. R., Yoshino, N., Taguchi, H. and Koeffler, H. P. 2006. Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. Leuk. Res. 30: 98-102.
38. Zanesi, N., Fidanza, V., Fong, L. Y., Mancini, R., Druck, T., Valtieri, M., Rüdiger, T., McCue, P. A., Croce, C. M. and Huebner, K. 2001. The tumor spectrum in FHIT-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98: 10250-10255.
39. Zheng, S., Ma, X., Zhang, L., Gunn, L., Smith, M. T., Wiemels, J. L., Leung, K., Buffler, P. A. and Wiencke, J. K. 2004. Hypermethylation of the 5 CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res. 64: 2000-2006.
40. Zöchbauer-Müller, S., Fong, K. M., Maitra, A., Lam, S., Geradts, J., Ashfaq, R., Virmani, A. K., Milchgrub, S., Gazdae, A. F. and Minna, J. D. 2001. 5 CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res. 61: 3581-3585.